Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ando

Showing results (131-140 of 241) with videos related to

Pageof 25
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 28, 2025
Clinical characteristics of immune checkpoint inhibitor-related pancreatic injury with pancreatitis in patients with advanced malignanciesTakaya Suzuki, Kazuyuki Mizuno, Takafumi Yamamoto, et al.
Molecular and Clinical Oncology|December 1, 2016
Muscle wasting associated with the long-term use of mTOR inhibitorsBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
Cancer Medicine|February 13, 2024
Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancerOsamu Maeda, Satoshi Furune, Mitsuro Kanda, et al.
Asia-Pacific Journal of Clinical Oncology|July 5, 2023
A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomyYao Liang, Osamu Maeda, Kazushi Miyata, et al.
Investigational New Drugs|December 6, 2011
First clinical pharmacokinetic dose-escalation study of sagopilone, a novel, fully synthetic epothilone, in Japanese patients with refractory solid tumorsKazuhiro Araki, Koichi Kitagawa, Hirofumi Mukai, et al.
Molecular and Clinical Oncology|October 4, 2014
Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancerOsamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, et al.
International Journal of Colorectal Disease|July 18, 2020
What is the impact of systemic chemotherapy for lateral lymph nodes in patients with locally advanced low rectal cancer?Atsushi Ogura, Kay Uehara, Toshisada Aiba, et al.
Cancer Science|August 21, 2020
Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trialYoshihiro Nishida, Shunsuke Hamada, Hiroshi Urakawa, et al.
International Journal of Environmental Research and Public Health|April 3, 2021
Multilevel Analysis of the Association of Dental-Hygienist-Related Factors on Regular Dental Check-Up BehaviorYuko Inoue, Yoshihiro Shimazaki, Akiko Oshiro, et al.
Cancer Science|September 13, 2006
Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancerKazuhiro Araki, Ken-ichi Fujita, Yuichi Ando, et al.
Pageof 25

Showing results (131-140 of 241) with videos related to

Sort By:
Pageof 25
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 28, 2025
Clinical characteristics of immune checkpoint inhibitor-related pancreatic injury with pancreatitis in patients with advanced malignanciesTakaya Suzuki, Kazuyuki Mizuno, Takafumi Yamamoto, et al.
Molecular and Clinical Oncology|December 1, 2016
Muscle wasting associated with the long-term use of mTOR inhibitorsBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
Cancer Medicine|February 13, 2024
Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancerOsamu Maeda, Satoshi Furune, Mitsuro Kanda, et al.
Asia-Pacific Journal of Clinical Oncology|July 5, 2023
A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomyYao Liang, Osamu Maeda, Kazushi Miyata, et al.
Investigational New Drugs|December 6, 2011
First clinical pharmacokinetic dose-escalation study of sagopilone, a novel, fully synthetic epothilone, in Japanese patients with refractory solid tumorsKazuhiro Araki, Koichi Kitagawa, Hirofumi Mukai, et al.
Molecular and Clinical Oncology|October 4, 2014
Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancerOsamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, et al.
International Journal of Colorectal Disease|July 18, 2020
What is the impact of systemic chemotherapy for lateral lymph nodes in patients with locally advanced low rectal cancer?Atsushi Ogura, Kay Uehara, Toshisada Aiba, et al.
Cancer Science|August 21, 2020
Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trialYoshihiro Nishida, Shunsuke Hamada, Hiroshi Urakawa, et al.
International Journal of Environmental Research and Public Health|April 3, 2021
Multilevel Analysis of the Association of Dental-Hygienist-Related Factors on Regular Dental Check-Up BehaviorYuko Inoue, Yoshihiro Shimazaki, Akiko Oshiro, et al.
Cancer Science|September 13, 2006
Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancerKazuhiro Araki, Ken-ichi Fujita, Yuichi Ando, et al.
Pageof 25